CHC Healthcare Group
TWSE:4164
Relative Value
The Relative Value of one CHC Healthcare Group stock under the Base Case scenario is 67.87 TWD. Compared to the current market price of 52.4 TWD, CHC Healthcare Group is Undervalued by 23%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
CHC Healthcare Group Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
TW |
CHC Healthcare Group
TWSE:4164
|
8.7B TWD | 2.3 | 25.6 | 10.5 | 22.7 | ||
US |
Mckesson Corp
NYSE:MCK
|
71.4B USD | 0.2 | 23.8 | 15.9 | 18.4 | ||
US |
Cencora Inc
NYSE:COR
|
44.2B USD | 0.2 | 23.9 | 11.8 | 16.4 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
23.7B USD | 0.1 | 42.9 | 8.8 | 11.7 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD | 0.8 | 24.5 | 12.5 | 17.6 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
70.4B HKD | 0.1 | 7.3 | 1.8 | 2.1 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
IT |
Amplifon SpA
MIL:AMP
|
7.7B EUR | 3.4 | 49.8 | 15.9 | 31.5 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 1.4 | 20 | 15.2 | 15.2 | ||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
53B CNY | 0.2 | 14.1 | 8.3 | 8.3 |